Spasticity News and Research

RSS
Spasticity is a condition involving an involuntary increase in muscle tone that leads to resistance against normal movements of the body and may cause pain in some individuals.
XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

Israeli scientists identify genetic cause of hereditary spastic paraparesis

Israeli scientists identify genetic cause of hereditary spastic paraparesis

Study: Marijuana use may affect cognitive skills in patients with MS

Study: Marijuana use may affect cognitive skills in patients with MS

New Pediatric Physical Medicine and Rehabilitation Service at NewYork-Presbyterian Hospital

New Pediatric Physical Medicine and Rehabilitation Service at NewYork-Presbyterian Hospital

XenoPort reports preliminary top-line results from arbaclofen placarbil Phase 2b clinical trial in GERD

XenoPort reports preliminary top-line results from arbaclofen placarbil Phase 2b clinical trial in GERD

Benefits and underutilization of ITB therapy for multiple sclerosis

Benefits and underutilization of ITB therapy for multiple sclerosis

Exciting progress made in MS research during 2010

Exciting progress made in MS research during 2010

Celebrity chef, registered dietitian team up to create nutrition program for people with MS

Celebrity chef, registered dietitian team up to create nutrition program for people with MS

Physiotherapy Associates announces new MS Specialty Program

Physiotherapy Associates announces new MS Specialty Program

Study raises questions about therapeutic use of botulinum toxin A

Study raises questions about therapeutic use of botulinum toxin A

FDA clears Multi-Lead Trialing Cable for SCS therapy

FDA clears Multi-Lead Trialing Cable for SCS therapy

GBS meningitis in infants still very serious

GBS meningitis in infants still very serious

XenoPort third quarter net loss decreases to $19.9 million

XenoPort third quarter net loss decreases to $19.9 million

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

UCSF scientists receive grants to refine embryonic stem cell-based strategies for neurological diseases

UCSF scientists receive grants to refine embryonic stem cell-based strategies for neurological diseases

Optogenetics helps to restore optimal movement in people with physical disabilities

Optogenetics helps to restore optimal movement in people with physical disabilities

XenoPort intends to initiate Phase 3 XP19986 trial for multiple sclerosis

XenoPort intends to initiate Phase 3 XP19986 trial for multiple sclerosis

Botox maker agrees to pay $600 million for misbranding

Botox maker agrees to pay $600 million for misbranding

Cerebral palsy risk rises in post term babies: Study

Cerebral palsy risk rises in post term babies: Study

Cannabis Science seeks entry into European medical cannabis market

Cannabis Science seeks entry into European medical cannabis market